Abstract

NEW APPROACHES IN THE MANAGEMENT OF METHICILLINRESISTANT STAPHYLOCOCCUS AUREUS (MRSA)

*Shahnooshi Javad F and Anita Dadollahi Sarab

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) are a growing issue worldwide with significant economic impact. As a pharmacist, you should be familiar with all the risk factors and treatment available now a day. A new antibiotic, tedizolid phosphate, appears to be a reasonable alternative to linezolid for the treatment of acute bacterial skin and skin structure infections (ABSSSI): A short (6-day) course of tedizolid phosphate was as effective as a 10-day course of linezolid with regard to both early and sustained clinical responses. Recently, new and unusual antibiotic compound has been extracted from a marine microorganism found in sediments off the coast of California, researcher also found that wearing gloves and gowns in intensive care units does not reduce overall rates of acquiring Methicillin-resistant Staphylococcus aureus (MRSA).

Keywords: new approaches, methicillin-resistant staphylococcus aureus, management, antibiotic, prevention.